Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Envoy Medical (COCH) Other Operating Expenses (2022 - 2026)

Envoy Medical's Other Operating Expenses history spans 5 years, with the latest figure at -$7.1 million for Q1 2026.

  • On a quarterly basis, Other Operating Expenses fell 37.4% to -$7.1 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$5.6 million, a 76.18% decrease, with the full-year FY2025 number at $2.1 million, down 15.43% from a year prior.
  • Other Operating Expenses hit -$7.1 million in Q1 2026 for Envoy Medical, down from $307000.0 in the prior quarter.
  • Over the last five years, Other Operating Expenses for COCH hit a ceiling of $1.5 million in Q1 2022 and a floor of -$7.1 million in Q1 2026.
  • Historically, Other Operating Expenses has averaged -$138974.0 across 5 years, with a median of $588000.0 in 2023.
  • Biggest five-year swings in Other Operating Expenses: skyrocketed 454.72% in 2023 and later tumbled 1184.52% in 2025.
  • Tracing COCH's Other Operating Expenses over 5 years: stood at $1.0 million in 2022, then fell by 27.9% to $747000.0 in 2023, then dropped by 9.64% to $675000.0 in 2024, then crashed by 54.52% to $307000.0 in 2025, then plummeted by 2420.2% to -$7.1 million in 2026.
  • Business Quant data shows Other Operating Expenses for COCH at -$7.1 million in Q1 2026, $307000.0 in Q4 2025, and $608000.0 in Q3 2025.